Management that reduces local inflammation, including proper compression, early cold therapy, and graded mobilization, can assist in limiting these signals
Researchers are also studying how GLP-1s may affect brain pathways involved in reward, motivation, cravings, and impulse control
For food and drink companies, the rise of GLP-1 medications is an industry earthquake
The explanation for the discrepancy in the reduction of MACE in patients treated with SGLT2i in DECLARE-TIMI 58 suggests that the benefits of SGLT2i may be more pronounced in patients with a higher risk of cardiovascular disease
Dayan is equally optimistic and cautious
Research-only is the legal product framing: strictly for research purposes and not for human or animal consumption